995112 Florida Senate - 2026 Committee Amendment SB2500 AHS 35 The Committee on Appropriations(Trumbull) recommended the following amendment:Section: 03 EXPLANATION: On Page: 089 Provides $350,000 in nonrecurring general revenue funds for Sickle Cell Disease Gene Therapy (SF Spec App: 308 1622). Reduces funding by the same amount from Fixed Capital Outlay for Centrally Managed Facilities. NET IMPACT ON: Total Funds General Revenue Trust Funds Recurring - 0 0 0 Non-Recurring - 0 0 0 ______________________________________________________________________________________ Positions & Amount Positions & Amount DELETE INSERT CHILDREN AND FAMILIES, DEPARTMENT OF Administration Program: Executive Leadership Executive Direction And Support Services 60900101 In Section 03 On Page 089 308 Fixed Capital Outlay 080751 Department Of Children And Family Services Fixed Capital Needs For Centrally Managed Facilities IOEJ 1000 From General Revenue Fund 6,300,000 5,950,000 CA -350,000 FSI1NR -350,000Section: 03 EXPLANATION: On Page: 127 Provides $350,000 in nonrecurring general revenue funds for Sickle Cell Disease Gene Therapy (SF Spec App: 481 1622). Reduces funding by the same amount from Fixed Capital Outlay for Centrally Managed Facilities. NET IMPACT ON: Total Funds General Revenue Trust Funds Recurring - 0 0 0 Non-Recurring - 0 0 0 ______________________________________________________________________________________ 995112 Log:0168 ABG/ABG 02/16/26 08:51:54 PM Senate Page: 1 Positions & Amount Positions & Amount DELETE INSERT HEALTH, DEPARTMENT OF Program: Community Public Health Disease Control And Health Protection 64200200 In Section 03 On Page 127 481 Special Categories 100778 Grants And Aids - Contracted Services IOEB 1000 From General Revenue Fund 500,000 850,000 CA 350,000 FSI1NR 350,000 INSERT: Sickle Cell Disease Gene Therapy (SF 1622).......................350,000995112 Log:0168 ABG/ABG 02/16/26 08:51:54 PM Senate Page: 2